1-deoxynojirimycin has been researched along with curcumin in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Al Eisa, N; Platt, FM; Smith, C; Smith, DA; Wallom, KL; Williams, IM | 1 |
Allocca, M; Andreotti, G; Cubellis, MV; Hay Mele, B; Liguori, L; Lukas, J; Monti, MC; Monticelli, M; Morretta, E | 1 |
2 other study(ies) available for 1-deoxynojirimycin and curcumin
Article | Year |
---|---|
Improved neuroprotection using miglustat, curcumin and ibuprofen as a triple combination therapy in Niemann-Pick disease type C1 mice.
Topics: 1-Deoxynojirimycin; Animals; Cerebellum; Curcumin; Drug Therapy, Combination; Ibuprofen; Intracellular Signaling Peptides and Proteins; Mice; Mice, Inbred BALB C; Mice, Knockout; Neuroprotective Agents; Niemann-Pick C1 Protein; Niemann-Pick Disease, Type C; Proteins | 2014 |
Curcumin Has Beneficial Effects on Lysosomal Alpha-Galactosidase: Potential Implications for the Cure of Fabry Disease.
Topics: 1-Deoxynojirimycin; alpha-Galactosidase; Curcumin; Fabry Disease; Galactose; Humans; Lysosomes; Mutation | 2023 |